Sign in

CIK 0000014272

  • Large accelerated filer

BRISTOL MYERS SQUIBB CO

Sign in to watch
Ticker
BMY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
220790350
Phone
+1 609-252-4621
Business address
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543

Securities

  • BMY Bristol-Myers Squibb Company Common Stock NYSE
  • CELG-RI Rights NYSE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$677,826
in 3 filings

Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-10 Eid Joseph SVP,Head Glob. Medical Affairs Shares withheld for taxes −348 $60.93 $21K 5,544
2021-03-10 Eid Joseph SVP,Head Glob. Medical Affairs Exercise or conversion +812 6,356
2021-03-10 Eid Joseph SVP,Head Glob. Medical Affairs Other acquisition +15 6,371
2021-03-10 Eid Joseph SVP,Head Glob. Medical Affairs Shares withheld for taxes −260 $60.93 $16K 6,111
2021-03-10 Eid Joseph SVP,Head Glob. Medical Affairs Exercise or conversion +3,751 9,862
2021-03-10 Eid Joseph SVP,Head Glob. Medical Affairs Other acquisition +730 10,592
2021-03-10 Eid Joseph SVP,Head Glob. Medical Affairs Shares withheld for taxes −1,405 $60.93 $86K 9,187
2021-03-10 Eid Joseph SVP,Head Glob. Medical Affairs Exercise or conversion · Market Share Units −625 626
2021-03-10 Eid Joseph SVP,Head Glob. Medical Affairs Exercise or conversion · Market Share Units −946 1,892
2021-03-10 Eid Joseph SVP,Head Glob. Medical Affairs Exercise or conversion · Market Share Units −812 2,438
2021-03-10 Eid Joseph SVP,Head Glob. Medical Affairs Grant or award · Market Share Units +3,265 3,265
2021-03-10 Eid Joseph SVP,Head Glob. Medical Affairs Exercise or conversion · Performance Shares −3,751 0
2021-03-10 Eid Joseph SVP,Head Glob. Medical Affairs Grant or award · Performance Shares +4,898 4,898
2021-03-10 Elkins David V EVP, Chief Financial Officer Exercise or conversion +8,025 91,211
2021-03-10 Elkins David V EVP, Chief Financial Officer Other acquisition +150 91,361
2021-03-10 Elkins David V EVP, Chief Financial Officer Shares withheld for taxes −4,329 $60.93 $264K 87,032
2021-03-10 Elkins David V EVP, Chief Financial Officer Exercise or conversion · Market Share Units −8,025 24,077
2021-03-10 Elkins David V EVP, Chief Financial Officer Grant or award · Market Share Units +32,171 32,171
2021-03-10 Elkins David V EVP, Chief Financial Officer Grant or award · Performance Shares +48,257 48,257
2021-03-10 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Exercise or conversion +4,189 9,082

Page 77 of 90 · 1,795 trades